3043 companies

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

SRRA

US$54.99

7D

0.06%

1Y

179.4%

OliX Pharmaceuticals

Market Cap: ₩1.9t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

A226950

₩94,000.00

7D

-6.1%

1Y

444.0%

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥9.5b

Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.

300119

CN¥20.93

7D

-4.6%

1Y

55.4%

Tilray Brands

Market Cap: US$1.3b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

TLRY

US$1.15

7D

-5.0%

1Y

-33.9%

Chengdu Easton Biopharmaceuticals

Market Cap: CN¥9.5b

Engages in the research, development, manufacture, and commercialization of pharmaceutical products.

688513

CN¥54.85

7D

-7.3%

1Y

49.4%

CARsgen Therapeutics Holdings

Market Cap: HK$10.3b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

2171

HK$18.63

7D

-11.5%

1Y

335.3%

HOB Biotech GroupLtd

Market Cap: CN¥9.4b

Operates as a in vitro diagnostic company in China and internationally.

688656

CN¥150.57

7D

-8.1%

1Y

496.3%

Ascletis Pharma

Market Cap: HK$10.3b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

1672

HK$10.34

7D

-3.2%

1Y

848.6%

Azenta

Market Cap: US$1.3b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

AZTA

US$28.56

7D

-8.1%

1Y

-42.2%

Sichuan Huiyu Pharmaceutical

Market Cap: CN¥9.4b

Research and develops, produces, and sells anti-tumor and injection drugs in China and internationally.

688553

CN¥22.30

7D

-9.2%

1Y

94.1%

Arcus Biosciences

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.

RCUS

US$12.84

7D

3.6%

1Y

-16.7%

PharmaBlock Sciences (Nanjing)

Market Cap: CN¥9.3b

Provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.

300725

CN¥40.68

7D

-2.1%

1Y

29.1%

Janux Therapeutics

Market Cap: US$1.3b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

JANX

US$23.23

7D

-0.9%

1Y

-49.8%

HitGen

Market Cap: CN¥9.3b

Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.

688222

CN¥23.31

7D

-6.5%

1Y

131.9%

ST PharmLtd

Market Cap: ₩1.8t

Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.

A237690

₩88,900.00

7D

-5.4%

1Y

-11.2%

Alivus Life Sciences

Market Cap: ₹115.2b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

ALIVUS

₹939.20

7D

-10.3%

1Y

-8.8%

GuangYuYuan Chinese Herbal Medicine

Market Cap: CN¥9.3b

GuangYuYuan Chinese Herbal Medicine Co., Ltd.

600771

CN¥18.93

7D

-2.3%

1Y

-6.7%

Syndax Pharmaceuticals

Market Cap: US$1.3b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

SNDX

US$15.68

7D

6.1%

1Y

-17.0%

Sanofi Consumer Healthcare India

Market Cap: ₹113.8b

Operates as a fast-moving consumer healthcare company in India.

SANOFICONR

₹4,940.50

7D

-4.1%

1Y

-3.2%

Nanjing Vazyme Biotech

Market Cap: CN¥9.1b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥22.88

7D

3.4%

1Y

11.6%

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.9b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

719

HK$7.16

7D

-3.2%

1Y

25.4%

Aurisco PharmaceuticalLtd

Market Cap: CN¥9.1b

Engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API’s), and formulations catering to the pharmaceutical market worldwide.

605116

CN¥22.33

7D

-1.5%

1Y

0.3%

Harbin Pharmaceutical Group

Market Cap: CN¥9.1b

Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.

600664

CN¥3.60

7D

-1.4%

1Y

5.6%

Xeris Biopharma Holdings

Market Cap: US$1.3b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

XERS

US$8.18

7D

6.0%

1Y

185.0%

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺52.7b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

GENIL

₺175.60

7D

4.2%

1Y

93.4%

Blue Jet Healthcare

Market Cap: ₹112.0b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

BLUEJET

₹645.90

7D

-4.9%

1Y

25.4%

Sunflower Pharmaceutical GroupLtd

Market Cap: CN¥9.0b

Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.

002737

CN¥15.40

7D

-1.7%

1Y

-29.1%

Zhejiang Hisoar Pharmaceutical

Market Cap: CN¥9.0b

Engages in the manufacture of pharmaceutical products and dyes in China and internationally.

002099

CN¥5.66

7D

-10.7%

1Y

-3.1%

Cisen Pharmaceutical

Market Cap: CN¥9.0b

Research, develops, produces, and sells drug products in China and internationally.

603367

CN¥19.84

7D

-5.0%

1Y

47.9%

Stoke Therapeutics

Market Cap: US$1.3b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

STOK

US$24.14

7D

5.4%

1Y

97.2%

Cosmo Pharmaceuticals

Market Cap: CHF 1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

COPN

CHF 62.80

7D

-6.4%

1Y

-17.5%

Acutaas Chemicals

Market Cap: ₹111.2b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

ACUTAAS

₹1,358.10

7D

-6.9%

1Y

58.5%

Changchun BCHT Biotechnology

Market Cap: CN¥8.9b

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally.

688276

CN¥21.44

7D

-2.8%

1Y

-18.4%

Sino BiologicalInc

Market Cap: CN¥8.8b

Provides recombinant protein and antibody reagents for life science researchers worldwide.

301047

CN¥72.70

7D

-9.1%

1Y

13.6%

Zhejiang Tianyu Pharmaceutical

Market Cap: CN¥8.8b

Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.

300702

CN¥25.69

7D

-2.8%

1Y

66.4%

Shandong Lukang PharmaceuticalLtd

Market Cap: CN¥8.8b

Operates as a pharmaceutical company in China.

600789

CN¥9.82

7D

-1.0%

1Y

26.5%

Page 14 of 85